Advances in CLL.
O' Brien
Susan
S
Professor and Internist, Department of Hematology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015415:Biomarkers; D017322:Clinical Trials, Phase II as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017353:Gene Deletion; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D011379:Prognosis; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine